-
Making Decisions About Breast Surgery
Patients who opt for breast reconstruction after mastectomy tend to overestimate how happy they will be with the results, while those who do not get reconstruction tend to underestimate their future satisfaction.
by Cici Zhang
-
A Better Way to Screen for Lynch Syndrome?
Researchers say a next-generation sequencing test could improve screening in colorectal cancer patients for a hereditary syndrome that raises cancer risk. Some experts have concerns.
by Cheryl Platzman Weinstock
-
Forward Look
Treating Early-Stage Lung CancerEfforts are underway to define role of high-dose radiation.
by Stephen Ornes
-
Survivor Profile
Family MattersAfter Shigeo Tsuruoka was diagnosed with stomach cancer, his family came together to help him. His daughter, Aki Smith, was by his side as he navigated treatment and recovery. Now she offers guidance to other stomach cancer patients and caregivers.
by Kate Yandell
-
Q&A
Keeping Options OpenResearch scientist Teresa Woodruff is determined to make fertility preservation accessible to more young adults and children with cancer.
by Delia O'Hara
-
Liver Cancer on the Rise
Liver cancer incidence and death rates are increasing rapidly. Although there is no screening test for the disease, minimizing risk factors—hepatitis B and C, smoking, obesity and type 2 diabetes—could prevent many cases from developing.
by Sue Rochman
-
Is 3-D Mammography Better?
A study enrolling patients compares a newer form of digital mammography to conventional 2-D digital mammography.
by Marci A. Landsmann
-
When Cancer Survivors Get Another Cancer
Patients diagnosed with a second cancer may be unnecessarily excluded from clinical trials.
by Kate Yandell
-
Forward Look
Young Survivors at Risk for HPV-Related CancersStudy finds low vaccination rates among teen survivors.
by Kate Yandell
-
Targeting Brain Cancer
Researchers are trying to understand brain cancer at the molecular level. Their goal is to find new, more effective therapies for this hard-to-treat disease.
by Stephen Ornes
Cancer Talk
Delaying Treatment Resistance
Adding a CDK 4/6 inhibitor extends progression-free survival for people with metastatic HR-positive, HER2-positive breast cancer.
by Thomas Celona
2024: The Year in Cancer NewsThe Cancer Today editors share the most impactful reporting on cancer research from 2024.
by Cancer Today staff
Cancer Today Editors’ Picks: 2024Our favorite Cancer Today stories from 2024, as picked by the editors.
Rethinking the Role of RadiationChest radiation may not be necessary for people with intermediate-risk breast cancer.
by Thomas Celona